affiliation not provided to SSRN
Insulin Resistance, Endometrial Cancer, HOMA-IR, Health Disparities, Postmenopausal Women
FES PET, estrogen receptor, metastatic breast cancer, Progression, Endocrine resistance, endocrine therapy, decision-making